UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Antimicrobial agents and chemotherapy, ISSN 0066-4804, 10/2016, Volume 60, Issue 10, pp. 6115 - 6120
Pharmacology & Pharmacy | Life Sciences & Biomedicine | Microbiology | Science & Technology | Diabetes Mellitus - pathology | Prevalence | Prospective Studies | Klebsiella Infections - pathology | Humans | Middle Aged | Virulence | Male | Klebsiella pneumoniae - classification | Phylogeny | Multilocus Sequence Typing | Cross Infection - pathology | beta-Lactamases - genetics | Pneumonia, Bacterial - pathology | Gene Expression | Pneumonia, Bacterial - complications | Plasmids - metabolism | Cross Infection - microbiology | Diabetes Mellitus - epidemiology | Plasmids - chemistry | Bacteremia - epidemiology | Bacteremia - pathology | Neoplasms - epidemiology | Intraabdominal Infections - complications | Klebsiella pneumoniae - isolation & purification | Diabetes Complications | Cross Infection - complications | Bacteremia - microbiology | Neoplasms - complications | Klebsiella Infections - epidemiology | Klebsiella pneumoniae - genetics | Adult | Female | beta-Lactamases - metabolism | Cross Infection - epidemiology | Pneumonia, Bacterial - microbiology | Intraabdominal Infections - microbiology | Neoplasms - microbiology | Phylogeography | Bacteremia - complications | Bacterial Proteins - genetics | Serogroup | Klebsiella Infections - complications | Pneumonia, Bacterial - epidemiology | China - epidemiology | Klebsiella Infections - microbiology | Intraabdominal Infections - epidemiology | Diabetes Mellitus - microbiology | Intraabdominal Infections - pathology | Klebsiella pneumoniae - pathogenicity | Bacterial Proteins - metabolism | Aged | Neoplasms - pathology | Index Medicus
Journal Article
Journal of antimicrobial chemotherapy, ISSN 0305-7453, 2017, Volume 72, Issue 5, pp. 1386 - 1395
Pharmacology & Pharmacy | Infectious Diseases | Life Sciences & Biomedicine | Microbiology | Science & Technology | Penicillanic Acid - pharmacology | Intraabdominal Infections - microbiology | Enterobacteriaceae Infections - microbiology | Humans | Europe - epidemiology | Pseudomonas aeruginosa - drug effects | Pseudomonas Infections - microbiology | Intraabdominal Infections - epidemiology | Microbial Sensitivity Tests | Enterobacteriaceae Infections - epidemiology | Urinary Tract Infections - epidemiology | Epidemiological Monitoring | Pseudomonas Infections - epidemiology | Turkey - epidemiology | Israel - epidemiology | Cross Infection - microbiology | Drug Resistance, Multiple, Bacterial | Enterobacteriaceae - drug effects | Urinary Tract Infections - microbiology | Anti-Bacterial Agents - pharmacology | Cephalosporins - pharmacology | Penicillanic Acid - analogs & derivatives | Index Medicus
Journal Article
Clinical infectious diseases, ISSN 1058-4838, 5/2015, Volume 60, Issue suppl_2, pp. S66 - S71
costs | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Clostridium Infections - economics | United States - epidemiology | Prevalence | Humans | Risk Factors | Clostridium difficile | Cost of Illness | Treatment Outcome | Clostridium Infections - epidemiology | Skilled Nursing Facilities | Anti-Bacterial Agents - therapeutic use | Anti-Bacterial Agents - adverse effects | Clostridium Infections - therapy | Clostridium Infections - mortality | Intraabdominal Infections - drug therapy | Cross Infection - epidemiology | Pathogens | Infectious diseases | Antibiotics | Drug resistance | Risk factors | Index Medicus
Journal Article
International journal of antimicrobial agents, ISSN 0924-8579, 2017, Volume 49, Issue 6, pp. 734 - 739
Infectious Disease | Gram-negative bacilli | Antimicrobial susceptibility | Intra-abdominal infection | Asia-Pacific region | Epidemiology | Extended-spectrum β-lactamase | Pharmacology & Pharmacy | Infectious Diseases | Life Sciences & Biomedicine | Microbiology | Science & Technology | Prospective Studies | Intraabdominal Infections - microbiology | Humans | Drug Resistance, Bacterial | Gram-Negative Bacteria - isolation & purification | Intraabdominal Infections - epidemiology | Gram-Negative Bacterial Infections - microbiology | Microbial Sensitivity Tests | Gram-Negative Bacteria - drug effects | Asia - epidemiology | Pacific Islands - epidemiology | Gram-Negative Bacterial Infections - epidemiology | Anti-Bacterial Agents - pharmacology | Abscess | Beta lactamases | Disease susceptibility | Health aspects | Antibacterial agents | Abdomen | Index Medicus
Journal Article
Journal of chemotherapy (Florence), ISSN 1120-009X, 04/2015, Volume 27, Issue 2, pp. 67 - 73
Susceptibility | Intra-abdominal infection | Ertapenem | Pharmacology & Pharmacy | Pathology | Oncology | Infectious Diseases | Life Sciences & Biomedicine | Science & Technology | Cholecystitis - drug therapy | Klebsiella pneumoniae - isolation & purification | Klebsiella pneumoniae - drug effects | Escherichia coli - drug effects | Humans | Abdominal Abscess - drug therapy | Ascitic Fluid - microbiology | Drug Resistance, Bacterial | Cholecystitis - microbiology | Incidence | Gram-Negative Bacterial Infections - microbiology | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Klebsiella Infections - epidemiology | Gram-Negative Aerobic Bacteria - drug effects | Drug Resistance, Multiple, Bacterial | Escherichia coli - growth & development | Cross Infection - epidemiology | Escherichia coli Infections - drug therapy | Length of Stay | Klebsiella Infections - drug therapy | Global Health | Intraabdominal Infections - microbiology | Escherichia coli Infections - microbiology | Abdominal Abscess - epidemiology | Gram-Negative Bacterial Infections - drug therapy | Klebsiella Infections - microbiology | Cross Infection - drug therapy | Intraabdominal Infections - epidemiology | Gram-Negative Aerobic Bacteria - growth & development | Abdominal Abscess - microbiology | Escherichia coli Infections - epidemiology | Gram-Negative Aerobic Bacteria - isolation & purification | Cholecystitis - epidemiology | Epidemiological Monitoring | Escherichia coli - isolation & purification | Cross Infection - microbiology | Gram-Negative Bacterial Infections - epidemiology | Klebsiella pneumoniae - growth & development | Anti-Bacterial Agents - pharmacology | Intraabdominal Infections - drug therapy | Index Medicus
Journal Article
Journal of antimicrobial chemotherapy, ISSN 0305-7453, 2017, Volume 72, Issue 5, pp. 1364 - 1372
Pharmacology & Pharmacy | Infectious Diseases | Life Sciences & Biomedicine | Microbiology | Science & Technology | Klebsiella pneumoniae - isolation & purification | Klebsiella pneumoniae - drug effects | Community-Acquired Infections - epidemiology | Escherichia coli - drug effects | Humans | Enterobacteriaceae - isolation & purification | Cefoxitin - pharmacology | Microbial Sensitivity Tests | Carbapenems - pharmacology | Escherichia coli - pathogenicity | Urinary Tract Infections - microbiology | Cross Infection - epidemiology | Intensive Care Units | Intraabdominal Infections - microbiology | Enterobacteriaceae - pathogenicity | Amikacin - pharmacology | Imipenem - pharmacology | Intraabdominal Infections - epidemiology | Urinary Tract Infections - epidemiology | beta-Lactams - pharmacology | Turkey - epidemiology | Escherichia coli - isolation & purification | Klebsiella pneumoniae - pathogenicity | Cross Infection - microbiology | Enterobacteriaceae - drug effects | Anti-Bacterial Agents - pharmacology | Community-Acquired Infections - microbiology | Index Medicus
Journal Article
The Journal of infectious diseases, ISSN 0022-1899, 04/2020, Volume 221, Issue Suppl 2, pp. S156 - S163
Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Multivariate Analysis | Klebsiella pneumoniae - drug effects | Humans | Middle Aged | Male | beta-Lactamases - genetics | Escherichia coli - pathogenicity | Female | Retrospective Studies | Cross Infection - epidemiology | Hospital Mortality | Gram-Negative Bacteria | Intraabdominal Infections - microbiology | Enterobacteriaceae Infections - microbiology | Risk Factors | Bacterial Proteins - genetics | Enterobacteriaceae Infections - mortality | Logistic Models | China - epidemiology | Cross Infection - drug therapy | Intraabdominal Infections - mortality | Molecular Epidemiology | Klebsiella pneumoniae - pathogenicity | Carbapenem-Resistant Enterobacteriaceae - pathogenicity | Aged | Anti-Bacterial Agents - pharmacology | Carbapenem-Resistant Enterobacteriaceae - drug effects | Intraabdominal Infections - drug therapy | Enterobacteriaceae Infections - drug therapy | Index Medicus | Abridged Index Medicus
Journal Article
Journal of internal medicine, ISSN 0954-6820, 06/2012, Volume 271, Issue 6, pp. 608 - 618
infections | deep venous thrombosis | pulmonary embolism | antibacterial agents | venous thromboembolism | Pulmonary embolism | Infections | Deep venous thrombosis | Antibacterial agents | Venous thromboembolism | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Cardiology. Vascular system | General aspects | Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous | Pharmacology. Drug treatments | Biological and medical sciences | Medical sciences | Blood and lymphatic vessels | Antibiotics. Antiinfectious agents. Antiparasitic agents | Prevalence | Humans | Middle Aged | Male | Pulmonary Embolism - epidemiology | Urinary Tract Infections - complications | Case-Control Studies | Cross Infection - complications | Venous Thromboembolism - drug therapy | Incidence | Outpatients - statistics & numerical data | Anti-Bacterial Agents - therapeutic use | Bacterial Infections - complications | Pulmonary Embolism - microbiology | Skin Diseases, Bacterial - complications | Female | Community-Acquired Infections - complications | Respiratory Tract Infections - complications | Odds Ratio | Venous Thromboembolism - epidemiology | Bacterial Infections - microbiology | Venous Thromboembolism - diagnosis | Acute Disease | Risk Assessment | Bacterial Infections - drug therapy | Risk Factors | Bacteremia - complications | Medical Records | Logistic Models | Inpatients - statistics & numerical data | Cross Infection - drug therapy | Pulmonary Embolism - diagnosis | Algorithms | Bacterial Infections - epidemiology | Venous Thromboembolism - microbiology | Denmark - epidemiology | Pulmonary Embolism - drug therapy | Aged | Intraabdominal Infections - complications | Index Medicus | Original
Journal Article
Journal of antimicrobial chemotherapy, ISSN 0305-7453, 07/2013, Volume 68, Issue 2, pp. ii45 - ii55
Complicated skin and soft-tissue infections | Complicated intra-abdominal infections | Non-interventional studies | Broad-spectrum antibacterial therapy | Polymicrobial infections | Pharmacology & Pharmacy | Infectious Diseases | Life Sciences & Biomedicine | Microbiology | Science & Technology | Skin Diseases, Bacterial - microbiology | Gram-Positive Bacteria - drug effects | Minocycline - pharmacology | Humans | Middle Aged | Minocycline - analogs & derivatives | Drug Resistance, Bacterial | Male | Skin Diseases, Bacterial - drug therapy | Gram-Negative Bacteria - isolation & purification | Anti-Bacterial Agents - therapeutic use | Skin Diseases, Bacterial - epidemiology | Minocycline - therapeutic use | Aged, 80 and over | Adult | Female | Soft Tissue Infections - drug therapy | Bacterial Infections - microbiology | Bacterial Infections - drug therapy | Intraabdominal Infections - microbiology | Europe | Treatment Outcome | Soft Tissue Infections - epidemiology | Intraabdominal Infections - epidemiology | Gram-Negative Bacteria - drug effects | Drug Therapy, Combination - methods | Soft Tissue Infections - microbiology | Bacterial Infections - epidemiology | Gram-Positive Bacteria - isolation & purification | Aged | Anti-Bacterial Agents - pharmacology | Intraabdominal Infections - drug therapy | Pathogens | Effectiveness | Antibiotics | Antimicrobial agents | Drug resistance | Drug therapy | Epidemiology | Index Medicus
Journal Article
The Lancet infectious diseases, ISSN 1473-3099, 2016, Volume 16, Issue 6, pp. 661 - 673
Infectious Disease | Life Sciences & Biomedicine | Infectious Diseases | Science & Technology | Intraabdominal Infections - microbiology | Azabicyclo Compounds - administration & dosage | Humans | Middle Aged | Male | beta-Lactamase Inhibitors - administration & dosage | Pseudomonas aeruginosa - drug effects | Urinary Tract Infections - drug therapy | Anti-Bacterial Agents - therapeutic use | Gram-Negative Bacteria - drug effects | Carbapenems - therapeutic use | Drug Resistance, Multiple, Bacterial | beta-Lactamase Inhibitors - therapeutic use | Ceftazidime - administration & dosage | Enterobacteriaceae - drug effects | Aged, 80 and over | Female | Urinary Tract Infections - microbiology | Aged | Ceftazidime - adverse effects | Intraabdominal Infections - drug therapy | Azabicyclo Compounds - adverse effects | Medical research | Drug resistance in microorganisms | Care and treatment | Abscess | Medicine, Experimental | Urinary tract infections | Health aspects | Epidemiology | Ceftazidime | Abdomen | Pseudomonas aeruginosa | Studies | Pneumonia | Berries | Antibiotics | Infections | Drug resistance | Urogenital system | Urinary tract diseases | Index Medicus
Journal Article